SUCLG2 and cancer: For instance, Wu et al. and Shen et al. reported that alterations in the TCA cycle enzymes, which SUCLG2 also contributes to, are indicative of a more malignant cancer phenotype, thus corroborating our observations (Wu et al., 2020; Shen et al., 2023).